Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
GUILFORD, Conn., Nov. 06, 2019 (GLOBE NEWSWIRE) -- InveniAI® Corporation, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation...
-
- CIMeld™, an AlphaMeld™ powered product for competitive/business intelligence, is set to launch at PharmaCI USA 2019 - Tailored suite of products to address high value questions accelerating...
-
Dr. Agrawal, a biopharma Strategy and R&D leader, brings scientific and technology expertise to a world-class board of directors at InveniAI. InveniAI establishes presence in Basel, Switzerland...
-
Albany - NY, Sept. 11, 2015 (GLOBE NEWSWIRE) -- A new Transparency Market Research report states that the global medical imaging reagents market stood at US$10.3 billion in 2012 and is expected to...
-
SUZHOU, China, June 08, 2015 (GLOBE NEWSWIRE) -- Suzhou NeuPharma Co., Ltd. today announced that it has initiated the first-in-human Phase I clinical trial of RX108 in Australia. RX108 is a...